Streptococcus pneumoniae

Pneumococcal pneumonia hospitalizes about 150,000 people in the United States each year, with a mortality rate of approximately 5-7 percent, or 1 in every 20 infected individuals.

Neumococo, or Streptococcus pneumoniae, is a gram-positive bacterium that typically appears in a diplococcal form. It is responsible for a significant number of infections such as pneumonia, sinusitis, peritonitis, and other severe invasive diseases including meningitis and septicemia. These infections are particularly common among the elderly, children, and immunocompromised individuals.

According to data from the European Centre for Disease Prevention and Control (ECDC), an estimated 400,000 to 600,000 cases of invasive pneumococcal disease occur in Europe each year. This includes cases of bacteremia (presence of the bacteria in the blood), meningitis, and other serious infections.

Hifas Biologics’ samples with actitivity against this pathogen